Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.

Wu KL, Beverloo B, Velthuizen SJ, Sonneveld P.

Clin Lymphoma Myeloma. 2007 Jan;7(4):280-5.

PMID:
17324335
2.

The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.

Sawyer JR.

Cancer Genet. 2011 Jan;204(1):3-12. doi: 10.1016/j.cancergencyto.2010.11.002. Review.

PMID:
21356186
3.

[The significance and current diagnostic options of cytogenetic changes in multiple myeloma].

Kuglík P, Filková H, Oltová A, Hájek R.

Vnitr Lek. 2006 Nov;52 Suppl 2:76-8. Review. Czech.

PMID:
18175433
4.

Hyperhaploid plasma cell myeloma.

Hoctor VT, Campbell LJ.

Cancer Genet. 2012 Jul-Aug;205(7-8):414-8. doi: 10.1016/j.cancergen.2012.05.004. Review.

PMID:
22868003
5.

Interpretation of cytogenetic results in multiple myeloma for clinical practice.

Rajan AM, Rajkumar SV.

Blood Cancer J. 2015 Oct 30;5:e365. doi: 10.1038/bcj.2015.92. Review.

6.

[Impact of tumorcytogenetics in tumor diagnostics].

Wenzel F, Röthlisberger B.

Ther Umsch. 2008 Sep;65(9):473-80. doi: 10.1024/0040-5930.65.9.473. Review. German.

PMID:
18791960
7.

Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytogénétique hématologique (GFCH).

Daudignon A, Quilichini B, Ameye G, Poirel H, Bastard C, Terré C.

Ann Biol Clin (Paris). 2016 Oct 1;74(5):588-595. Review.

PMID:
27707673
8.

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

Munshi NC, Anderson KC, Bergsagel PL, Shaughnessy J, Palumbo A, Durie B, Fonseca R, Stewart AK, Harousseau JL, Dimopoulos M, Jagannath S, Hajek R, Sezer O, Kyle R, Sonneveld P, Cavo M, Rajkumar SV, San Miguel J, Crowley J, Avet-Loiseau H; International Myeloma Workshop Consensus Panel 2..

Blood. 2011 May 5;117(18):4696-700. doi: 10.1182/blood-2010-10-300970. Epub 2011 Feb 3.

9.

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, Morgan G, Van Ness B, Chesi M, Minvielle S, Neri A, Barlogie B, Kuehl WM, Liebisch P, Davies F, Chen-Kiang S, Durie BG, Carrasco R, Sezer O, Reiman T, Pilarski L, Avet-Loiseau H; International Myeloma Working Group..

Leukemia. 2009 Dec;23(12):2210-21. doi: 10.1038/leu.2009.174. Epub 2009 Oct 1. Review.

10.

Implications of heterogeneity in multiple myeloma.

de Mel S, Lim SH, Tung ML, Chng WJ.

Biomed Res Int. 2014;2014:232546. doi: 10.1155/2014/232546. Epub 2014 Jul 2. Review.

11.

The genetic architecture of multiple myeloma.

Prideaux SM, Conway O'Brien E, Chevassut TJ.

Adv Hematol. 2014;2014:864058. doi: 10.1155/2014/864058. Epub 2014 Apr 3. Review.

Supplemental Content

Support Center